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ABSTRACT Genetic studies have identified several epithelial-derived genes associated with airway
diseases. However, techniques used to study gene function frequently exceed the proliferative potential of
primary human bronchial epithelial cells (HBECs) isolated from patients. Increased expression of the
polycomb group protein BMI-1 extends the lifespan of HBECs while maintaining cell context plasticity.
Herein we aimed to assess how BMI-1 expression impacted cellular functions and global mRNA
expression. HBECs from six donors were transduced with lentivirus containing BMI-1 and cells were
characterised, including by RNA sequencing and impedance measurement. BMI-1-expressing HBECs (B-
HBECs) have a proliferative advantage and show comparable in vitro properties to low passage primary
HBECs, including cell attachment/spreading and barrier formation. The B-HBEC mRNA signature was
modestly different to HBECs, with only 293 genes differentially expressed (5% false discovery rate). Genes
linked to epithelial mesenchymal transition and cell cycle were enriched in B-HBECs. We investigated the
expression of genes implicated in asthma from genetic and expression studies and found that 97.6% of
genes remained unaltered. We have shown that increased BMI-1 expression in HBECs delays lung
epithelial cell senescence by promoting cell cycle progression and highlighted the flexible utility for B-
HBECs as an important platform for studying airway epithelial mechanisms.
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The proximal airway epithelium is a critical defensive barrier that protects underlying tissues from inhaled
pathogens and environmental particles by orchestrating innate and adaptive immune responses. In chronic
airway diseases such as asthma there is growing evidence that the airway epithelium is fundamentally
different in a number of aspects, including the epigenome and transcriptome [1], cell composition [2], and
barrier properties [3]. Genome-wide association studies (GWASs) and RNA-sequencing studies have
identified numerous genetic variants (e.g. within IL33, TSLP gene loci [4, 5]) and differentially expressed
genes of relevance to the airway epithelium (CEACAM5, CPA3, INSR, MS4A2, NOX1, and SLC16A6 [6]).
Many genes identified from these studies are novel and thus their contribution to airway disease have yet
to be elicited and importance defined.
Culturing primary human bronchial epithelial cells (HBECs) isolated from healthy controls or asthmatic
patients at the air–liquid interface (ALI) is the gold standard for studying physiologically relevant lung
epithelial biology [7]. However, the short lifespan (3–4 passages) of primary airway epithelial cells when
cultured in vitro, is insufficient for many in vitro techniques such as CRISPR/cas9 gene editing and single
cell cloning prior to ALI. Thus, there is a need for a cell culture model with an enhanced lifespan
potential, whilst retaining the plasticity and phenotype of primary epithelial cells. This is particularly
important as the bronchoscopy procedure to isolate cells has significant risks to the donor.
There have been numerous different approaches to resolve primary epithelial cell senescence, including
culturing cells with Rho-associated protein kinase (ROCK) inhibitors, seeded on a layer of irradiated
feeder cells [8]. Whilst such methods allow normal epithelial cells to proliferative indefinitely in vitro, it is
complex and time-consuming when compared to standard cell culture methods. Alternative methods have
overexpressed proteins such as human telomerase reverse transcriptase (hTERT) within cells to
successfully extend their proliferative potential [9]. However, hTERT-expressing cells have been shown to
lose the ability to differentiate at early passage and be genetically unstable [9, 10]; two key elements
required comparable to wild type cells for in vitro disease research.
B-cell-specific Moloney murine leukaemia virus integration site 1 (BMI-1) is a polycomb group protein
that is critical in regulating cell senescence through suppression of the cyclin-dependent kinase inhibitor,
p16INK4A [11, 12]. We have shown that cells engineered to overexpress BMI-1 retain key phenotypes of
primary bronchial epithelial cell cultures up to passage 15, including the ability to differentiate at the ALI
and a normal karyotype, which has been robustly replicated by others [10, 13]. However, all of these
studies have lacked the fundamental understanding of the global gene expression profile that is
manipulated, deregulated and controlled in the context of BMI-1 overexpression. This is essential if we are
to expand and effectively utilise this important lung cell culture platform for basic and disease biology.
In this study, we have addressed the previously uncharacterised biology of this lung cell model system. We
have 1) evaluated the BMI1-HBEC (B-HBEC) system in detail as a platform representative of primary
human airway epithelium at both the cellular and molecular level; 2) developed an inducible BMI-1 system
that can be silenced allowing a research platform directly comparable to low passage donor cells; and 3)
evaluated the utility of the platform to investigate genes implicated in asthma.
Materials and methods
Primary bronchial epithelial cell culture
Normal HBECs (N-HBECs) were purchased from Lonza (Wokingham, UK) (supplementary table S1).
N-HBECs were grown in BEGM (Lonza) supplemented with 13 mg·mL−1 bovine pituitary extract,
0.5 mg·mL−1 hydrocortisone, 0.5 µg·mL−1 human recombinant epidermal growth factor, 0.5 mg·mL−1
epinephrine, 10 mg·mL−1 transferrin, 5 mg·mL−1 insulin, 0.1 µg·mL−1 retinoic acid, 6.5 µg·mL−1
triiodothyronine, 30 µg·mL−1 gentamicin and 5 ng·mL−1 amphotericin as previously described [7].
Production of genetically modified HBECs
Full length human BMI-1 was amplified and cloned into a pLVX-Puro constitutive vector (Clontech) and
a pCDH-CuO-MCS-IRES-RFP (SparQ) inducible vector (System Biosciences). pLVX-Puro-BMI-1,
SparQ-BMI-1 and pCDH-EF1-CymR-T2A-Puro (System Biosciences) vectors were packaged into pCMV
delta R8.9 and pCMV-VSV-G lentivirus envelope and packaging vectors. Passage 2 N-HBECs from six
donors were transduced with pLVX-Puro-BMI-1 lentivirus solution to produce HBECs that constitutively
express BMI-1 (B-HBEC), as described previously [10]. These B-HBECs were continued in culture through
additional passages 3, 4, 5 and 6. To generate an inducible BMI-1 cell line, N-HBECs from five donors
were transduced with SparQ-BMI-1 lentivirus solution and pCDH-EF1-CymR-T2A-Puro lentivirus
solution (1:3 ratio). Additional details are described in the supplementary material.
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MTT assay
A total of 2.5×103 cells were seeded onto a 96-well plate in 200 µL of BEGM. Cells were incubated for 72 or
96 h. Medium was replaced with 200 µL 0.5 mg·mL−1 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) dissolved in BEGM. Cells were incubated with MTT at 37°C for 4 h. MTT solution was
replaced with 200 µL isopropanol and incubated for 10 min. The absorbance of the solution was measured at
570 nm (subtracting the 690 nm background) using a Flexstation 3 microplate reader (Molecular Devices,
Wokingham, UK).
DAPI staining
Cells suspended in BEGM were transferred into a Via-1 Cassette, lined with acridine orange and
4′,6-diamidino-2-phenylindole (DAPI) and analysed on a Nucleocounter NC-3000 (Chemometec, Allerod,
Denmark).
Electric cell-substrate impedance sensing
The 8W10E arrays (IBIDI, Munich, Germany) were treated with 200 µL 10 mM L-cysteine dissolved in
sterile water for 15 min at room temperature. Wells were washed 3× with 300 µL sterile water. Then,
200 µL PureCol Type 1 bovine collagen solution (Advanced Biomatrix, San Diego, CA, USA) diluted 1 in
100 in sterile water, was added to wells and incubated at 37°C overnight. Wells were washed 3× with
BEGM. Then, 400 µL BEGM was added to each well and the array was stabilised in the electric
cell-substrate impedance sensing (ECIS) Zθ instrument (Applied Biophysics, Troy, NY, USA). Medium
was replaced with 7.5×104 cells in BEGM. The array was run at multiple frequencies (including the
specific frequencies of 400 Hz and 32 kHz) for 72 h continuously on the ECIS Zθ instrument, as described
previously [14].
Two-step cell cycle assay
A total of 4×105 cells were centrifuged at 400×g for 5 min. Pellets were washed with PBS then resuspended
in 100 µL lysis buffer (Chemometec) containing 10 µg·mL−1 DAPI (Chemometec) and incubated at 37°C
for 5 min. Then, 100 µL stabilisation buffer (Chemometec) was added to the solution and 30 µL of sample
was transferred into an NC-Slide A2 (Chemometec). A two-step cell cycle assay was run on a
Nucleocounter NC-3000 (Chemometec). Data were exported as an FCS file and analysed using FlowJo
software. The cell cycle distribution for 10000 cells was automatically quantified using the cell cycle
modelling algorithm as described [15].
RNA extraction and isolation
Cells were grown in T75 flasks until 80% confluent. RNA was isolated using an RNeasy Mini Kit
(QIAGEN, Manchester, UK) following the manufacturer’s protocol. RNA integrity number was assessed
using the 2100 Bioanalyser (Agilent, Didcot, UK).
RNA sequencing
Library preparation is described in the supplementary material. Paired-end (75 bp) sequencing was
performed using a HiSeq4000 platform, HiSeq 3000/4000 PE Cluster kit and 150 cycle SBS kit (Illumina,
Cambridge, UK), generating a raw read count of ∼30 million reads per sample.
Analysis of RNA sequencing
Alignment of RNA-sequencing reads to genome build GRCh37 was carried out using TopHat package
[16]. Analysis of RNA-sequencing files was performed using the Cufflinks package [16] as performed
previously [17]. Principal-component analysis (PCA) was completed using the R package prcomp using
FPKM values generated by Cuffnorm and PCA plots were produced using ggplot2. Additional details are
described in the supplementary material.
Lookup of asthma-related genes
A lookup of asthma-related genes was performed in the generated RNA-sequencing datasets. Asthma-related
genes were identified from the most recent and largest asthma GWAS [5] and from meta-analyses of gene
expression in bronchial epithelial brush samples from asthma patients and controls [6].
Statistical analysis
For cell-based outcomes, a paired t-test was used to determine differences between N-HBECs and
B-HBECs. To determine whether BMI-1 expression altered cell cycle phase frequency, a two-way ANOVA
with Sidak’s multiple comparisons test was performed. p<0.05 was considered significant.
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Results
BMI-1 does not change the viability of HBECs
To determine the effects of BMI-1 upregulation on cell viability, an MTT assay was performed. The cell
viability of passage 3 (P3) N-HBECs were compared to passage 6 (P6) B-HBECs from six donors
(supplementary table S1). At both 72 and 96 h, there was a nonsignificant increase in cell viability in five
of six B-HBEC donors (figure 1a and b). Staining with DAPI to assess cell viability also showed no
difference between B-HBECs and N-HBECs populations (figure 1c).
BMI-1 expression alters cell cycle distribution of HBECs
We observed a significant decrease of 12% in the frequency of B-HBECs within the G1/G0 phase
(p<0.001) and an increase of 9% in G2/M phase cells (p<0.01) when compared to N-HBECs (figure 1d
and supplementary figure S1).
BMI-1 does not impact cell spreading or tight junction formation in HBECs
To assess how BMI-1 overexpression impacted cell adherence, spreading or tight junction formation we
performed ECIS. In all comparisons of N-HBEC versus B-HBEC no difference was observed for
capacitance (cell spreading/adherence) or resistance (tight junction formation), highlighting that B-HBECs
are not different from N-HBECs in these properties (figure 2).
Constitutive overexpression of BMI1 in N-HBECs produces a transcriptional response
To determine how BMI-1 expression affected HBECs at the transcriptome level, RNA sequencing was
performed using RNA isolated from early passage (P2) N-HBECs and P5 B-HBECs (figure 3a). PCA of
N-HBECs and B-HBECs identified significant overlap in the sample datasets with no obvious outliers
(supplementary figure S2). We first confirmed that all six HBECs donors transduced with pLVX-BMI-1













































































FIGURE 1 Phenotypic properties of BMI-1-expressing human bronchial epithelial cells (B-HBECs) and normal
human bronchial epithelial cells (N-HBECs). Basic cell phenotypes of passage 3 N-HBECs and passage 6
B-HBECs derived from the same matched donors. a and b) An MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay was performed to assess cell viability; cells were incubated for 72 h (a)
and 96 h (b) before the addition of MTT. c) Cell viability determined through DAPI staining and counted on a
Chemometec Nucleocounter NC-3000. d) The cell cycle phase distribution in N-HBECs and B-HBECs
determined through a two-step cell cycle assay with cell cycle phase frequency, calculated using the Watson
pragmatic algorithm. Values represent the median and 95% confidence interval (n=6). A paired t-test (a–c),
two-way ANOVA and Sidak’s multiple comparison test (d) were used to determine statistical significance. **:
p<0.01; ***: p<0.001.
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the 19190 transcripts evaluated, 293 genes (1.5%) were differentially expressed at 5% false discovery rate
(FDR). There were 161 genes that were upregulated and 132 were downregulated in B-HBECs compared to
N-HBECs (figure 3c). The top 10 upregulated genes based on magnitude of effect and p-value were;
GUSBP2, HAS2, THY1, DENND2A, TOX2, CSF3, CPNE7, ATP1A3, BCL2A1, KIAA1644 and those
downregulated were; COX7A1, HEATR6, SPINK7, ATP12A, PROSP, MUC15, SPRR3, CALB1, SBSN, KRT13
(table 1 and figure 3c). We observed multiple changes to extracellular matrix proteins, including increases
in collagen genes (COL4A1, COL4A2, COL22A1) and decreases in cytokeratin genes (KRT4, KRT10,
KRT13, KRT16, KRT23) in B-HBECs (supplementary table S2 for complete list). A heat map was
generated using genes with a five-fold or greater change in expression, demonstrating that there was
heterogeneity at the donor level. However, the expression profiles of N-HBECs and B-HBECs are visibly
distinct for these highest differentially expressed genes (figure 3d).
Gene set enrichment analysis shows that genes involved in cell cycle regulation are altered in
B-HBECs
To provide an insight into how BMI-1 expression affected the biological processes of bronchial epithelial


































































































FIGURE 2 The effects of BMI-1 on human bronchial epithelial cell (HBEC) adherence, spreading and tight
junction formation, in vitro. Passage 3 normal HBECs (N-HBECs) and passage 6 BMI-1-expressing HBECs
(B-HBECs) were seeded on an 8W10E array (IBIDI) and cultured for 72 h. Resistance was measured at 400 Hz
(barrier formation) and capacitance at 32 kHz (cell adherence and spreading). Raw resistance (a) and
capacitance (b) profile of N-HBECs (blue) and B-HBECs (red), values represent mean and SEM (n=6). Total
area under the curve from resistance (c) and capacitance (d) profile over 72 h. Area under the curve from
resistance profile at 36–72 h (e) and capacitance at 0–36 h (f ). A paired t-test was used to determine
statistical significance (c–f ).
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FIGURE 3 RNA sequencing analysis of BMI-1-expressing human bronchial epithelial cells (B-HBECs) versus
normal human bronchial epithelial cells (N-HBECs). a) Schematic showing the RNA-sequencing pipeline.
Scythe/Sickle trimmed Fastq files (.fastq) were aligned to the GRCh37 human genome assembly to produce
BAM files (.bam) with an average of ∼40 million mapped reads using the TopHat software package. Cufflinks
and Cuffmerge were used for transcript assembly and Cuffnorm and Cuffdiff were used for normalised and
differential gene expression, respectively. b) Total BMI-1 expression (FPKM) in P2 N-HBECs and P5 B-HBECs.
Statistical analysis was carried out using a paired t-test (****: p<0.0001). c) 293 genes were differentially
expressed between B-HBECs and N-HBECs with 132 downregulated and 161 upregulated (5% false discovery
rate). Coloured dots represent differentially expressed genes (q<0.05) and labelled genes are the top 10
differentially expressed genes ranked firstly on q-value then on fold change. d) Genes that showed a >5-fold
change in expression (q=0.006). Red represents over expressed, and blue attenuated genes.
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(upregulated by BMI-1) whilst 20 pathways were enriched in N-HBECs (downregulated by BMI-1) at 5%
FDR (supplementary table S3). The most upregulated pathways in B-HBECs consisted of genes involved in
epidermal growth factor receptor (EGFR) signalling (normalised enrichment score (NES) 2.23), cell-cycle
regulated genes (NES 2.06 and 2.04) and epithelial mesenchymal transition (EMT) (NES 2.02) (table 2).
The top downregulated pathway in B-HBECs involved genes in intestinal cells in response to co-culture with
probiotic bacteria (NES −2.11) and mucociliary differentiation (NES −2.01). These gene and pathway data 1)
indicate that BMI-1 expression induces changes in the expression profile of several pathways and 2) provide
an expression map for researchers interested in using this platform for specific pathway-related questions.
BMI-1 expression in an inducible model is not reversible and shows heterogeneity
In addition to the constitutive B-HBEC cell line, we developed a second-generation cell system with
inducible BMI-1-expression HBECs (IB-HBECs) controlled through a cumate switch. We confirmed that
IB-HBECs cultured in the presence of cumate have significantly upregulated BMI-1 transcripts (*p<0.05).
However, withdrawal of cumate had either no effect or a modest decrease on BMI-1 expression levels
(figure 4a). Overall, 104 genes out of 16384 assayed (0.6%), were differentially expressed between
N-HBECs and IB-HBECs cultured in the presence of cumate (supplementary table S4). This is markedly
fewer than we observed in the constitutive B-HBEC system (figure 4b). Of these, 74 genes were
upregulated, whilst 30 genes were downregulated in comparison to N-HBECs. The top 10 upregulated
genes included: NES, S100A7, TSPAN18, NTRK1, BMI1/COMMD3, ANPEP, B4GALNT1, COL8A2, CA14
and HEPHL1 and downregulated genes included: CLCA4, AC005702.1/AC005702.4, KRT13, KRT4, MSMB,
NDN, ATP12A, CRNN, ALDH3A1 and METTL7A ranked as previously (figure 4b). It is evident that
TABLE 1 Top 10 upregulated and downregulated genes in B-HBECs (P5) compared to N-HBECs (P2) ranked firstly on q-value





HAS2 +42 Hyaluronan synthase 2. Hyaluronan or hyaluronic acid is a constituent of the extracellular matrix. It serves a
variety of functions, including space filling, lubrication of joints and provision of a matrix through which
cells can migrate.
THY1 +16 Thy-1 cell surface antigen. The encoded protein is involved in cell adhesion and cell communication in
numerous cell types, but particularly in cells of the immune and nervous systems.
DENND2A +15 DENN domain containing 2A. Guanine nucleotide exchange factor, which may activate RAB9A and RAB9B.
Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active
GTP-bound form.
TOX2 +12 TOX high mobility group box family member 2. Gene Ontology annotations related to this gene include
chromatin binding and RNA polymerase II transcription factor binding.
CSF3 +10 Colony stimulating factor 3. The protein encoded by this gene is a cytokine that controls the production,
differentiation and function of granulocytes.
CPNE7 +9 Copine 7. Calcium-dependent membrane-binding proteins.
ATP1A3 +9 ATPase Na+/K+ transporting subunit α3. The protein encoded by this gene belongs to the family of p-type
cation transport ATPases, and to the subfamily of Na+/K+ -ATPases.
BCL2A1 +8 BCL2 Related protein A1. This gene encodes a member of the BCL-2 protein family. The proteins of this
family form hetero- or homodimers and act as anti- and proapoptotic regulators that are involved in a wide
variety of cellular activities such as embryonic development, homeostasis and tumourigenesis.
KIAA1644 +7 Unknown function.
COX7A1 -Infinite Cytochrome C oxidase subunit 7A1. Cytochrome c oxidase, the terminal component of the mitochondrial
respiratory chain, catalyses the electron transfer from reduced cytochrome c to oxygen.
HEATR6 −70 Diseases associated with HEATR6 include breast cancer.
SPINK7 −44 Serine peptidase inhibitor, Kazal type 7. Probable serine protease inhibitor.
ATP12A −43 ATPase H+/K+ transporting nongastric α2 subunit. The protein encoded by this gene belongs to the family of
P-type cation transport ATPases.
PROSP −32 Pseudogene.
MUC15 −29 Mucin 15. Cell surface Associated. May play a role in the cell adhesion to the extracellular matrix.
SPRR3 −14 Small proline rich protein 3. Among its related pathways are keratinisation and developmental biology.
CALB1 −14 Calbindin 1. This protein is thought to buffer entry of calcium upon stimulation of glutamate receptors.
SBSN −13 Suprabasin. Diseases associated with SBSN include adenoid cystic carcinoma.
KRT13 −12 Keratin 13. The keratins are intermediate filament proteins responsible for the structural integrity of
epithelial cells and are subdivided into cytokeratins and hair keratins.
N-HBEC: normal human bronchial epithelial cell; B-HBEC: BMI-1-expressing human bronchial epithelial cells.
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N-HBECs have a distinct expression profile compared to IB-HBECs and that there is no distinct difference
between IB-HBECs that have BMI-1 expression switched on (+cumate) and IB-HBECs that have BMI-1
silenced (−cumate) (figure 4c and supplementary table S5). Finally, we compared the expression profile of
constitutive and inducible B-HBECs, of the total 293 genes that were differentially expressed between
B-HBECs and N-HBECs, just 20 of those genes were also differentially expressed between IB-HBECs and
N-HBECs (figure 4d).
BMI-1 constitutive expressing cell platform has a physiologically valid utility for asthma research
To begin to address the utility of the BMI-1 constitutive cell lines for asthma research we investigated the
expression profile of genes implicated in asthma in the most recent and largest GWAS [5] and in a
TABLE 2 Gene set enrichment analysis was carried out to identify differentially regulated pathways between P2 N-HBECs and
P5 B-HBECs
NAME Direction SIZE ES NES FDR
q-value
Leading edge
KOBAYASHI EGFR SIGNALING_24HR_DN Upregulated 244 0.74 2.23 0 tags: 74%, list:
16%, signal: 88%
ROSTY CERVICAL CANCER PROLIFERATION CLUSTER Upregulated 137 0.74 2.13 0 tags: 84%, list:
18%, signal: 102%
SOTIRIOU BREAST CANCER GRADE 1_VS_ 3 UP Upregulated 146 0.74 2.13 0 tags: 85%, list:
18%, signal: 103%
MANALO HYPOXIA DN Upregulated 282 0.69 2.11 0 tags: 65%, list:
15%, signal: 75%
DUTERTRE ESTRADIOL_RESPONSE_24HR UP Upregulated 316 0.68 2.10 0 tags: 68%, list:
15%, signal: 80%
BLUM RESPONSE TO_SALIRASIB_DN Upregulated 340 0.66 2.06 0 tags: 70%, list:
18%, signal: 85%
ZHOU CELL CYCLE GENES IN IR RESPONSE 6HR Upregulated 82 0.77 2.06 0 tags: 78%, list:
14%, signal: 91%
ZHOU CELL CYCLE GENES IN IR RESPONSE 24HR Upregulated 123 0.73 2.04 0 tags: 77%, list:
17%, signal: 93%
SARRIO EPITHELIAL MESENCHYMAL TRANSITION UP Upregulated 173 0.69 2.02 0 tags: 73%, list:
18%, signal: 88%
FOURNIER ACINAR_DEVELOPMENT_LATE_2 Upregulated 270 0.66 2.01 0 tags: 64%, list:
16%, signal: 76%
TIEN INTESTINE PROBIOTICS_24HR_DN Downregulated 213 −0.69 −2.11 0 tags: 82%, list:
21%, signal: 103%
BOSCO EPITHELIAL DIFFERENTIATION MODULE Downregulated 69 −0.75 −2.01 2.57×10−4 tags: 74%, list:
18%, signal: 90%




Downregulated 126 −0.68 −1.98 4.69×10−4 tags: 83%, list:
23%, signal: 107%
REACTOME PEPTIDE_CHAIN_ELONGATION Downregulated 102 −0.72 −1.98 5.86×10−4 tags: 87%, list:
23%, signal: 113%
RICKMAN HEAD_AND_NECK_CANCER_E Downregulated 87 −0.71 −1.94 0.00184 tags: 71%, list:
17%, signal: 85%
REACTOME 3_UTR_MEDIATED_TRANSLATIONAL REGULATION Downregulated 123 −0.66 −1.93 0.00203 tags: 71%, list:
19%, signal: 87%
REACTOME TRANSLATION Downregulated 165 −0.63 −1.88 0.00587 tags: 66%, list:
19%, signal: 82%
REACTOME NONSENSE MEDIATED DECAY ENHANCED BY
THE_EXON JUNCTION_COMPLEX
Downregulated 123 −0.64 −1.87 0.00609 tags: 80%, list:
23%, signal: 103%
HOLLERN EMT_BREAST_TUMOR_DN Downregulated 95 −0.65 −1.82 0.01532 tags: 51%, list:
12%, signal: 57%
143 pathways were significantly (q<0.05) enriched in B-HBECs and 20 were enriched in the N-HBECs (top 10 shown ranked on q-value and
then ES). Size indicates the number of genes in the gene set after filtering out those not in the expression dataset.N-HBEC: normal human
bronchial epithelial cell; B-HBEC: BMI-1-expressing human bronchial epithelial cells; ES: enrichment score for the gene set, which is the
degree that the gene set is over-represented at the top or bottom of the ranked list of genes in the expression dataset; NES: normalised
enrichment score; FDR q-value: false discovery rate adjusted p-value, which is the estimated probability that the NES represents a false
positive; leading edge subset: subset of members that contribute the most to the ES; tags: percentage of genes contributing to the ES.
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FIGURE 4 RNA sequencing analysis of inducible BMI-1-expressing human bronchial epithelial cells
(B-HBECs) cultured with and without cumate. a) Total BMI-1 expression (FPKM) in P2 normal human
bronchial epithelial cells (N-HBECs), P5 inducible HBECs (IB-HBECs) in the presence of cumate and P6
IB-HBECs with cumate washed out. Statistical analysis carried out with a Friedman test with Dunn’s multiple
comparisons test (*: p<0.05). b) 104 genes are differentially expressed between BMI-1-expressing and
endogenous cells with 74 genes upregulated and 30 genes downregulated (5% false discovery rate). Coloured
dots reached q<0.05 and labelled genes are the top 10 differentially expressed genes ranked firstly on q-value
then fold change. c) Genes that showed a >5-fold change in expression (q=0.006) between IB-HBECs and
N-HBECs, including the expression levels after cumate withdrawal. Red represents high expression and blue
low. d) Venn diagram showing the proportion of genes that are differentially expressed in both the constitutive
and inducible B-HBEC systems.
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meta-analyses of gene expression in bronchial epithelial brush samples from asthma patients and controls
[6]. We identified that out of the 289 genes implicated in these studies that had quantitative data available,
282 (97.6%) were not altered in B-HBECs versus N-HBECs (supplementary table S6).
Discussion
In this study we aimed to 1) evaluate the B-HBEC system in detail as a platform representative of primary
human airway epithelium at both the cellular and transcriptional level; 2) develop an IB-HBEC system that
can be silenced allowing a research platform with extended lifespan and directly comparable to low
passage donor cells; and 3) evaluate the utility of the platform to investigate genes implicated in asthma.
Our data demonstrate that B-HBECs retain the cellular phenotype of primary N-HBECs from the same
donors including cell viability and properties such as cell attachment, spreading and tight junction
formation, extending our previous work. At the transcriptional level, upregulation of BMI-1 in HBECs
affected global gene expression, equivalent to 1.5% of transcripts tested and provide a useful dataset prior
to utilising these cells for specific research questions. Our evaluation of the B-HBEC platform specifically
for asthma showed that 97.6% of genes implicated in asthma were not affected by BMI-1 overexpression,
supporting the use of the platform in asthma research. Overall, these data provide the first in-depth
characterisation of this research platform, supporting its utility in asthma research where the airway
epithelium has been implicated in disease mechanisms and where obtaining cell samples from control
subjects and asthma patients comes with associated risk.
There have been a number of attempts to enhance the replicative lifespan of HBECs predominantly
through viral oncoproteins such as SV40 large T-antigen transformation [18, 19], or HPV-16 [20].
Alternatively, overexpression of hTERT alone has been shown to successfully delay cell senescence [21].
Whilst several of these cell lines retain key epithelial cell properties, they do have limitations (e.g. hTERT
cells lose the ability to form a resistive barrier and have chromosomal abnormalities) [10, 21].
The transcriptional repressor, BMI-1, is part of the polycomb repressive complex-1 and one of the target
genes of this complex is thought to be CDKN2A (p16INK4A) [22]. We have confirmed downregulation of
p16 protein previously [10] and now show that B-HBECs progress through the G1/S checkpoint more
readily compared to N-HBECs. Downregulation of CDKN2A was observed in our differential gene
expression analysis (mean FPKM 32, (range 21–46) in N-HBEC versus mean FPKM 20, (range 9–26) in
B-HBEC); however, this did not reach statistical significance.
BMI-1 is implicated in a number of different cancers largely due to its role in stem-cell renewal but also
its regulation of proliferation [23–25]. Collectively, when we compared the cell viability of N-HBECs and
B-HBECs, no statistically significant difference was observed, although individually 5/6 B-HBEC donors
showed an increase. We also observed no difference in cell viability between N-HBECs and B-HBECs,
although cell viability was high (>85%) in each cell line.
ECIS has previously been shown to be a sensitive and noninvasive technique for measuring multiple in
vitro properties of bronchial epithelial cells [26]. We showed that N-HBECs and B-HBECs attach and
spread in a highly similar manner. Previous studies have found that upregulation of BMI-1 results in the
downregulation of E-cadherin and the upregulation of EMT markers [27–29]. One limitation of ECIS is
that cells are cultured in an undifferentiated state and therefore not representative of in vivo conditions.
However, we have previously shown that differentiated B-HBECs develop a resistive barrier comparable to
N-HBECs when cultured at ALI [10], indicating that a robust epithelial barrier model can be achieved.
This is particularly of relevance to asthma, as bronchial epithelial cells isolated from asthma patients have
defective barrier properties [3] and the BMI-1 platform may be useful to extend the lifespan of patient
cells for mechanistic studies.
Previous studies that have manipulated BMI-1 expression have shown widespread changes to gene
expression as a consequence [30]. BMI-1−/− in neural progenitor cells resulted in over 500 genes being
upregulated alone [31]. We identified 293 genes to be differentially expressed due to BMI-1 upregulation
(5% FDR). Although a significant number, a comparison of gene expression between in vivo airway
epithelia and differentiated airway epithelial cells cultured at the ALI, found 453 genes that were
differentially expressed with a more stringent <1% FDR [32]. Whilst BMI-1 expression did not result in
widespread changes in expression to key epithelial cell markers, significantly, BMI-1 downregulated
transcripts that are associated with epithelial differentiation pathways (KRT4, KRT13, SPINK5, CEACAM5/
6, SPRR1A and SPRR1B). KRT4 and KRT13 are markers of a newly identified transitional cell identified in
the mouse airway [33], a finding which requires further investigation.
We observed many pathways (>150) that were significantly altered by BMI-1. The most upregulated
pathway in B-HBECs consisted of genes involved in EGFR signalling, a pathway that has previously been
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associated with chronic airway diseases such as asthma [34, 35]. The regulatory role that BMI-1 has in the
cell cycle has been well characterised and it was therefore anticipated that two of the most enriched
pathways in B-HBECs related to cell cycle genes [36, 37]. BMI-1 expression also increased expression of
genes associated with cell proliferation and EMT; these findings are supported by the literature linking
BMI-1 to multiple different cancers [24, 25, 38, 39]. This characterisation provides information for
researchers using this platform.
The use of BMI-1 to expand the replicative lifespan of HBECs will potentially allow us to capture the
phenotype of HBECs derived from bronchial brushes for a range of respiratory disease patients including
asthma. Our data from these analyses indicate that the upregulation of BMI-1 does not reduce inter-donor
variability. Furthermore, BMI-1 has previously been utilised to delay cell senescence in cystic fibrosis cells,
whilst retaining their disease phenotype [13]. The extended lifespan of these cells gives researchers more
scope for experiments such as CRISPR/cas9 gene editing and single cell cloning prior to ALI expansion.
This is challenging in primary airway cells as ALI is required to be performed on early passage cells,
limiting the capacity of the cells to undergo manipulation prior to ALI.
GWAS and RNA-sequencing studies of asthma have identified multiple candidate genes linked to disease
and we found that the majority of these (97.6%) were not influenced by BMI-1 overexpression, supporting
the use of this platform. Seven of these genes were significantly differentially regulated by BMI-1 over
expression (downregulated: SERPINB7, CYP2J2, UPK1B, SNTB1 and CEACAM5; upregulated: ITGB6 and
EFNB2).
To avoid the effects of prolonged BMI-1 expression we also produced an inducible BMI-1 HBEC platform,
regulated by a cumate switch system. We observed significant upregulation of BMI-1 in IB-HBECs
cultured in cumate-supplemented medium, although more heterogeneous than the constitutive system.
When cumate was withdrawn from the culture medium, BMI-1 expression did not return to basal levels
observed in N-HBECs, although some donors did show a reduction. This finding, further supported by
the limited concordance in B-HBEC and IB-HBEC transcriptomes, suggests that the inducible platform
has limited utility.
The major limitation of this study is that we did not overexpress BMI-1 in cells isolated from asthma
patients to compare to healthy controls, however this was beyond the primary aim of the present study.
We have previously shown that BMI-1 HBECs maintain the ability to differentiate and form an epithelial
barrier at ALI; however, it is as yet unclear as to whether BMI-1-overexpressing cells derived from asthma
patients would exhibit an altered phenotype at the ALI [10]. It is also important to note that several
changes observed in the B-HBECs are relevant to asthma phenotypes including changes to matrix
proteins, mucociliary differentiation, EGFR signalling and EMT [35, 40]. Therefore, additional caution and
characterisation is required prior to B-HBECs being confirmed as a suitable cell model for asthma
mechanisms.
In conclusion, this study highlights the utility of the constitutive BMI-1 platform for capturing and
studying the phenotype of airway epithelial cells, whilst retaining interdonor variability. This provides a
platform to investigate disease mechanisms over prolonged periods and reducing reliance on bronchial
brushes and biopsies, procedures that are invasive and present a risk for patients with airway disease.
Finally, the extended lifespan of cells will provide a platform for more challenging mechanistic studies that
may require frequent cell passaging (e.g. CRISPR/Cas9 gene and variant editing).
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